Bank OZK

Executive Summary

BUY, Medium conviction. OZK rates a BUY, Medium conviction, with a $68.82 price target representing 35.6% upside from $50.77. The stock is inexpensive relative to regional-bank peers and management has laid out a credible 2027 acceleration, but investors should expect a volatile Q4 as RESG repayments temporarily reduce balances. The best entry is on evidence that CIB deposit and loan momentum is carrying through the payoff cycle.

Investment Thesis

The market is valuing OZK as a regional bank with a difficult real-estate runoff problem, not as a lender rebuilding its growth engine around CIB. That skepticism is understandable. RESG balances can fall in Q4 even after a strong Q3, and the bank has explicitly said charge-offs will remain elevated into 2027. But the payoff pressure also creates the opportunity: the equity price does not appear to recognize what the franchise can earn once CIB originations, deposits, and fee products become the larger business.

The case depends first on management converting CIB momentum into retained balances, rather than simply replacing runoff with new originations. The evidence is encouraging but incomplete. Treasury-management investment supported meaningful deposit growth, and the CIB platform now spans corporate banking, fund finance, equipment finance, asset-based lending, and related relationship products. This is a better mix than dependence on a single construction and development cycle. The second dependency is credit. Lower special-mention balances and the quarterly low in charge-offs are favorable early signals, but not proof that losses have peaked. OREO resolution timing is a material swing factor because management is prioritizing value maximization over quick sales.

Valuation provides the margin for these unresolved issues. At $50.77, the stock trades below book value despite an LTM operating margin of 38.2% and LTM net margin of 27.8%. The market is paying for a challenged balance trajectory, not for a return to sustained expansion. That asymmetry supports ownership through a normal Q4 retracement, provided subsequent disclosures show CIB production converting into loans and deposits while credit metrics do not deteriorate.

Conviction remains Medium because this is not a clean near-term momentum purchase. Shares are already above their $48.43 200-day average, and a high-short-interest setup can amplify both a good and bad earnings outcome. The underwriting is attractive only if management's FY2027 growth plan survives the next two quarters of RESG runoff and reserve pressure.

Key Metrics

Financial Strength

The balance sheet appears manageable on the supplied figures: debt/equity is 0.20 as of September 30, 2026, and debt/EBITDA is 1.67x LTM, rather than an aggressive leverage profile. Profitability remains strong for a bank, but the declining FY2025 operating margin and the unexplained current-quarter EBITDA datapoint mean margin quality should not be treated as fully settled. The key balance-sheet question is asset quality through the RESG payoff and OREO cycle, not liquidity data, which was not provided.

Competitive Position

OZK's advantage is specialized underwriting in large, complex real-estate and commercial relationships, paired with a CIB platform that can originate loans, gather operating deposits, provide treasury services, and produce fee income. The current RESG payoff cycle shows that specialization does not eliminate cyclicality. Durability improves if CIB becomes the larger balance, because a broader commercial customer base is less dependent on development timing and property-market liquidity.

Management & Guidance

Management guides to 3%-5% FY2026 loan growth, then 10%-12% FY2027 loan growth, with low-single-digit FY2027 net-interest-income growth and high-single-digit non-interest-income growth. The outlook explicitly accommodates a Q4 balance retracement, making it more credible than a forecast that ignores the runoff. Credibility is supported by the recent earnings record but remains conditional on the bank demonstrating that CIB growth can overcome continued elevated charge-offs and several-quarter OREO resolution timelines.

Segment Analysis

• Corporate and Institutional Banking (Not disclosed): Q3 growth was led by CIB, and CIB deposits increased over 20% QoQ; management expects it to surpass RESG balances in 2027.
• Real Estate Specialties Group (Not disclosed): RESG remains the near-term swing factor, with $690M of payoffs and paydowns in the first 19 days of October and potential record Q4 repayments.
• Community Banking and Indirect Lending (Not disclosed): Both contributed to Q3 loan growth; Indirect Lending launched powersports on October 1 and has booked its first transactions.

Capital Allocation

The supplied LTM financial data reports $0.6B FCF, while the deep-dive deployment feed reports $0.0B for FCF, capex, buybacks, and dividends and does not provide a period label. That discrepancy prevents a firm conclusion on shareholder-return policy. Capital discipline should be judged by whether management uses balance-sheet capacity to fund high-return CIB relationships rather than pursuing growth to offset RESG runoffs at weaker underwriting terms.

Management Execution & Track Record

The 2024 Q4 call promised mid- to high-single-digit FY2025 loan growth despite RESG headwinds, about 10% expense growth for investment, and CIB as the leading growth contributor. The available FY2025 outcome shows 16.0% revenue growth but only 2.0% EPS growth, while actual FY2025 loan growth, expense growth, and the long-term efficiency-ratio result are not supplied, so management cannot be credited with meeting those specific commitments. Directionally, CIB did become the growth engine and is now expected to overtake RESG in 2027, consistent with the prior strategy. Earnings execution has been adequate rather than flawless, with six beats and two misses across the eight supplied quarters, including the latest $1.50 EPS versus $1.43 expected. The current call's reported Q3 EBITDA of $0.00B and 0.0% margin is not reconciled to LTM profitability data, limiting confidence in that operating metric.

Positioning & Flows

Ownership is highly concentrated, with the top three institutions holding 84.2% and reported insider ownership of 0.0%. BlackRock, Dimensional Fund Advisors, State Street, and Vanguard are among the leading holders, making the register institutionally driven rather than insider-led. Positive options gamma and a $46.86 zero-gamma level, 7.76% below spot, provide near-term technical support, while the high short base creates upside squeeze potential if the January report validates CIB-led growth.

Bull Case

• Management expects CIB to exceed RESG balances in 2027, broadening the loan mix beyond real-estate lending and across 44 three-digit NAICS codes.
• Management expects high-single-digit FY2027 non-interest-income growth, with another record Q4 fee-income quarter expected excluding historical bargain-purchase gains.
• Credit trends improved in Q3, producing the year's lowest quarterly net-charge-off ratio and lower special-mention balances.
• Operating-unit reengineering reduced headcount by 94 over the past two quarters, creating room for positive operating leverage as CIB scales.

Bear Case

• RESG payoffs and paydowns reached $690M in the first 19 days of October, and management says Q4 balances may retrace despite strong originations.
• Management expects net charge-offs to remain elevated through 2026 and 2027, while OREO resolutions may require several quarters.
• FY2025 EPS grew only 2.0% YoY to $6.21, showing that strong FY2027 volume guidance has not yet translated into sustained bottom-line growth.
• Short interest is 18.90% of the float, or 18,893,668 shares with 13.7 days-to-cover, signaling a sizeable cohort positioned for a credit or growth disappointment.

Valuation & Price Target

Engine price target $68.82 (+35.6% vs current), Medium confidence.

• P/E Multiple: $59.05 (28% weight)
• PEG (growth-adjusted): $143.28 (7% weight)
• P/S Multiple: $63.85 (20% weight)
• Quality-adjusted: $56.59 (20% weight)
• DCF: $97.41 (5% weight)

The rating agrees with the quant baseline BUY, but the Medium conviction reflects execution risk rather than blind acceptance of the engine's $68.82 target. Valuation support is clear across the $59.05 P/E, $63.85 P/S, and $56.59 quality-adjusted methods, while the $143.28 PEG and $97.41 DCF outputs require growth assumptions that have not yet been proven through the payoff cycle. The model's 54/100 quality score and 64/100 Moderate risk score fit that balance. Sell-side consensus is a low-signal counterpoint, with 0 buys, 3 holds, and 1 sell across only four firms; it does not outweigh management's specific 2027 growth plan or the valuation discount.

Risk Assessment

Risk score 64/100 (Moderate). The central risk is that the $690M RESG payoff wave becomes persistent rather than transitional, preventing CIB growth from delivering management's 10%-12% FY2027 loan-growth target.

The Bottom Line

OZK is rated BUY, Medium conviction for investors who can hold through a payoff-driven Q4. The stock offers a large valuation discount to peers while management is repositioning growth toward CIB and fee-generating relationships. January results need to confirm that this is a temporary balance dip, not a shrinking franchise. The rating would change if RESG runoff continues to overwhelm CIB production, credit losses worsen beyond management's elevated-loss outlook, or FY2027 loan-growth guidance is reduced.